Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
This paragraph explains how to identify dividend ETFs with the lowest management fees and compare options side by side.
27,460 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Oil has eased from double-digit spikes as tensions with Iran ease, nudging markets toward calmer inflation expectatio...
Energy refuses quit: stocks are steering a broad market rally, with the Energy Select Sector SPDR Fund powering highe...
Two tech giants just reported blowout results. This guide breaks down what the numbers mean and how to decide which g...
A rising concentration in a handful of tech names is signaling a wall street flashing warning for many investors. Thi...
After years of policy shifts and supply hiccups, a clearer EV roadmap is starting to emerge. This analysis explains w...
Broadcom faced a sharp intraday drop that contrasted with a broader Nasdaq rally, highlighting a rotation in tech lea...
Choosing the right index fund in retirement matters more than most people realize. This guide breaks down SP500 vs to...
U.S. M2 hit a fresh high in January 2026, but Bitcoin hasn’t followed the traditional liquidity playbook. Here’s what...
As AI rivals surge and cloud demand shifts, investors question Microsoft’s staying power in the Magnificent 7. The de...
The GRID fund has surged about 23% in 2026, outpacing the traditional utilities ETF XLU as AI-enabled grid modernizat...
Micron Technology has stunned investors with a massive year-long rally. This article breaks down the drivers behind t...